Surveillance for Antiviral-Agent-Resistant Herpes Simplex Virus in the General Population with Recurrent Herpes Labialis-Reference-Cited by-同舟云学术

Surveillance for Antiviral-Agent-Resistant Herpes Simplex Virus in the General Population with Recurrent Herpes Labialis

Published:2002-09 Issue:9 Volume:46 Page:3042-3044
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Bacon Teresa H.¹,Boon Ron J.¹,Schultz Margaret²,Hodges-Savola Cheryl³

Affiliation:

1. GlaxoSmithKline Consumer Healthcare, Weybridge, Surrey KT15 0DE, United Kingdom

2. GlaxoSmithKline Pharmaceuticals, Research Triangle Park, North Carolina 27709

3. ViroMed Inc., Minneapolis, Minnesota 55343

Abstract

ABSTRACT In a general population survey in the United States, the prevalence of antiviral-agent-resistant herpes simplex virus was very low among more than 1,000 isolates from individuals with an episode of recurrent herpes labialis not treated with topical antiviral agents. Two isolates had borderline resistance to acyclovir (0.2%), and all were susceptible to penciclovir.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.46.9.3042-3044.2002

Reference9 articles.

1. Boon, R. J., T. H. Bacon, H. L. Robey, T. J. Coleman, A. Connolly, P. Crosson, and S. L. Sacks. 2000. Antiviral susceptibilities of herpes simplex virus from immunocompetent subjects with recurrent herpes labialis: a UK-based study. J. Antimicrob. Chemother.46:324-325. (Erratum, 46:1051.)

2. Survey of Resistance of Herpes Simplex Virus to Acyclovir in Northwest England

3. Collins, P., and M. N. Ellis. 1993. Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir. J. Med. Virol.1993(Suppl. 1):58-66.

4. Sacks, S. L., R. A. Thisted, T. M. Jones, R. A. Barbarash, D. J. Mikolich, G. E. Ruoff, J. L. Jorizzo, L. B. Gunnill, D. H. Katz, M. H. Khalil, P. R. Morrow, G. J. Yakatan, L. E. Pope, and J. E. Berg for the Docosanol 10% Cream Study Group. 2001. Clinical efficacy of topical docosanol 10% cream for herpes simplex labialis: a multicenter, randomized, placebo-controlled trial. J. Am. Acad. Dermatol.45:222-230.

5. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The immunobiology of corneal HSV-1 infection and herpetic stromal keratitis;Clinical Microbiology Reviews;2024-09-12

2. Acyclovir‐resistant HSV‐1 isolates among immunocompromised patients in southern Taiwan: Low prevalence and novel mutations;Journal of Medical Virology;2023-07-28

3. Acyclovir resistance in herpes simplex viruses: Prevalence and therapeutic alternatives;Biochemical Pharmacology;2022-12

4. Anti-Herpes Virus Activity Of Lactobacillus’ Postbiotics;BioMedicine;2022-02-23

5. Anti-herpetic Activity of Macrocystis pyrifera and Durvillaea antarctica Algae Extracts Against HSV-1 and HSV-2;Frontiers in Microbiology;2020-09-11